Figure 6. Immunological evaluation and drug sensitivity analysis. (A–D) TIDE, dysfunction, exclusion and MSI Expr Sig scores compared between two groups. (E) TCIA for predicting sensitivity to immunotherapy. (F) ROC curves comparing risk, TIDE, and TIS at OS. (G) Correlation between riskscore and chemotherapeutic sensitivity.